Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Frazier Healthcare Partners has completed the acquisition of Altruix, a healthcare services other business in California. Frazier Healthcare Partners acquires Altruix to expand capabilities in healthcare services, supporting care delivery operations and related services. Altruix provides healthcare services that fit Frazier Healthcare Partners acquisitions strategy for growth across the sector. The platform acquisition is a private equity acquisition, with Randy Hyun appointed as Chief Executive Officer to lead the combined organization. Terms and deal size were not disclosed, and the healthcare M&A transaction closed as a platform buildout.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026